Improved Detection of Candida sp fks Hot Spot Mutants by Using the Method of the CLSI M27-A3 Document with the Addition of Bovine Serum Albumin

被引:28
作者
Garcia-Effron, Guillermo [1 ]
Park, Steven [1 ]
Perlin, David S. [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA
关键词
REDUCED ECHINOCANDIN SUSCEPTIBILITY; FLUCONAZOLE-RESISTANT CANDIDA; IN-VITRO SUSCEPTIBILITY; INVASIVE CANDIDIASIS; GLOBAL SURVEILLANCE; AMPHOTERICIN-B; CASPOFUNGIN; MICAFUNGIN; ALBICANS; ANIDULAFUNGIN;
D O I
10.1128/AAC.01350-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Echinocandins are highly bound to serum proteins, altering their antifungal properties. The addition of 50% human serum to the MIC assay improves the identification of echinocandin-resistant Candida spp. harboring fks hot spot mutations. However, this modification cannot readily be applied to the method of the CLSI M27-A3 document due to safety and standardization difficulties. The aim of this study was to evaluate commercial bovine serum albumin (BSA) as a safe and standardized alternative to human serum. A collection of 28 echinocandin-susceptible strains, 10 Candida parapsilosis sensu lato strains (with naturally reduced echinocandin susceptibility), and 40 FKS hot spot mutants was used in this work. When RPMI 1640 was used for susceptibility testing, wild-type strains and fks mutants showed MIC range overlaps (-2, -1, and -3 2-fold-dilution steps separated these populations for anidulafungin, caspofungin, and micafungin, respectively). On the other hand, the addition of BSA to RPMI 1640 differentially increased echinocandin MIC values for these groups of strains, allowing better separation between populations, with no MIC range overlaps for any of the echinocandin drugs tested. Moreover, the use of RPMI-BSA reduced the number of fks hot spot mutant isolates for which MIC values were less than or equal to the upper limit for the wild type (very major errors) from 9, 2, and 7 with RPMI alone to 3, 0, and 3 for anidulafungin, caspofungin, and micafungin, respectively. When RPMI-BSA was used to study the susceptibility of C. parapsilosis sensu lato species to echinocandins, the strains behaved as anidulafungin- and micafungin-resistant isolates (MIC,>= 8 mu g/ml). These data support the need for a revision of the CLSI protocol for in vitro testing of echinocandin susceptibility in order to identify all or most of the fks hot spot mutants. Also, caspofungin could be used as a surrogate marker of reduced susceptibility to echinocandins.
引用
收藏
页码:2245 / 2255
页数:11
相关论文
共 43 条
[1]   Role of plasma proteins in pharmacokinetics of micafungin, an antifungal antibiotic, in analbuminemic rats [J].
Abe, Fumie ;
Ueyama, Jun ;
Kawasumi, Noriyo ;
Nadai, Masayuki ;
Hayashi, Tamon ;
Kato, Miki ;
Ohnishi, Masafumi ;
Saito, Hiroko ;
Takeyama, Naoshi ;
Hasegawa, Takaaki .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) :3454-3456
[2]  
[Anonymous], 2008, Approved standard M27-A. A National Committee for Clinical Laboratory Standards
[3]   Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media [J].
Arendrup, Maiken Cavling ;
Garcia-Effron, Guillermo ;
Lass-Floerl, Cornelia ;
Gomez Lopez, Alicia ;
Rodriguez-Tudela, Juan-Luis ;
Cuenca-Estrella, Manuel ;
Perlin, David S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) :426-439
[4]   Echinocandins for candidemia in adults without neutropenia [J].
Bennett, John E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1154-1159
[5]   In Vitro Fungicidal Activities of Echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis Evaluated by Time-Kill Studies [J].
Canton, Emilia ;
Espinel-Ingroff, Ana ;
Peman, Javier ;
del Castillo, Lucas .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) :2194-2197
[6]   Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains [J].
Castanheira, Mariana ;
Woosley, Leah N. ;
Diekema, Daniel J. ;
Messer, Shawn A. ;
Jones, Ronald N. ;
Pfaller, Michael A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) :2655-2659
[7]   Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during Candidemia treatment [J].
Cleary, John D. ;
Garcia-Effron, Guillermo ;
Chapman, Stanley W. ;
Perlin, David S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2263-2265
[8]   Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds [J].
Cuenca-Estrella, Manuel ;
Gomez-Lopez, Alicia ;
Mellado, Emilia ;
Monzon, Araceli ;
Buitrago, Maria J. ;
Rodriguez-Tudela, Juan L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :2192-2195
[9]   Mutations in the fks1 gene in Candida albicans, C-tropicalis, and C-krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing [J].
Desnos-Ollivier, Marie ;
Bretagne, Stephane ;
Raoux, Dorothee ;
Hoinard, Damien ;
Dromer, Francoise ;
Dannaoui, Eric .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) :3092-3098
[10]   Multilocus sequence typing of Candida glabrata reveals geographically enriched clades [J].
Dodgson, AR ;
Pujol, C ;
Denning, DW ;
Soll, DR ;
Fox, AJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) :5709-5717